Baseline Characteristics of the Intention-to-Treat KARISMA Population

Baseline Characteristics of the Intention-to-Treat Population

Sustainability, Free Full-Text

Job Analysis, PDF, Recruitment

Description of included studies and populations.

Andrea DISCACCIATI, Karolinska Institutet, Solna, KI, Department of Medical Epidemiology and Biostatistics

Mikael ERIKSSON, PhD, PhD, Karolinska Institutet, Solna, KI, Department of Medical Epidemiology and Biostatistics

Baseline Characteristics of the Study Population. Baseline

2. Baseline Characteristics: Experiments and clinical

Signe BORGQUIST, Associate Professor, Senior Consultant, MD, PhD, Division of Oncology and Pathology/Clinical Trial Unit

Description of included studies and populations.

JCI - Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions